Insights into the Experiences of Persons with Substance Use Disorders During COVID-19 Lockdown in Lagos, Nigeria: A Qualitative Investigation

Overview

Journal Subst Use

Specialty Psychiatry

Date 2024 Dec 18

PMID 39691942

Authors

Samuel Ojima Adejoh

Peter Osazuwa

Sofiat Busari-Akinbode

Rosilyn Gborogen

Abolaji Awodein

Waziri Adisa

Titi Tade

Fatai Adesina Badru

Affiliations

Soon will be listed here.

Abstract

Objective: This study investigated the impact of COVID-19 lockdown on the consumption of illicit drugs among Persons with Substance Use Disorders in Lagos, Nigeria.

Methods: Using convenience sampling, 25 participants, who use different substances consented to participate in the study. Data was collected using in-depth interview guide and thematically analysed using NVivo 12 Plus.

Findings: The findings show that activities of celebrities on social media were motivation for use. There was an increase in the consumption of illicit drugs during the COVID-19 lockdown period among the participants. Participants were able to purchase illicit drugs from street vendors despite the lockdown restriction, while others bought from online retailers - the social media platforms. Participants reported an increase in the price of substances and a reduction in their quantity and quality during the lockdown which may likely account for the increase in consumption reported.

Conclusion: The lockdown, though used in curtailing the spread of COVID-19, had an unintended increase in the consumption of illicit drugs suggesting that drug markets can be resilient and adaptive during global crises.

References

Kumpfer K, Turner C . The social ecology model of adolescent substance abuse: implications for prevention. Int J Addict. 1990; 25(4A):435-63. DOI: 10.3109/10826089009105124. View

Slavova S, Rock P, Bush H, Quesinberry D, Walsh S . Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020; 214:108176. PMC: 7351024. DOI: 10.1016/j.drugalcdep.2020.108176. View

Scherbaum N, Bonnet U, Hafermann H, Schifano F, Bender S, Grigoleit T . Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany. Front Psychiatry. 2021; 12:648273. PMC: 8102785. DOI: 10.3389/fpsyt.2021.648273. View

Zolopa C, Burack J, OConnor R, Corran C, Lai J, Bomfim E . Changes in Youth Mental Health, Psychological Wellbeing, and Substance Use During the COVID-19 Pandemic: A Rapid Review. Adolesc Res Rev. 2022; 7(2):161-177. PMC: 8881192. DOI: 10.1007/s40894-022-00185-6. View

Van Hout M, Bingham T . Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. Int J Drug Policy. 2013; 25(2):183-9. DOI: 10.1016/j.drugpo.2013.10.009. View

Bergeron A, Decary-Hetu D, Giommoni L . Preliminary findings of the impact of COVID-19 on drugs crypto markets. Int J Drug Policy. 2020; 83:102870. PMC: 7391953. DOI: 10.1016/j.drugpo.2020.102870. View

Arillotta D, Guirguis A, Corkery J, Scherbaum N, Schifano F . COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis. Brain Sci. 2021; 11(7). PMC: 8303488. DOI: 10.3390/brainsci11070907. View

Farhoudian A, Radfar S, Mohaddes Ardabili H, Rafei P, Ebrahimi M, Zonoozi A . A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic. Front Psychiatry. 2021; 12:646206. PMC: 8377291. DOI: 10.3389/fpsyt.2021.646206. View

Cherian R, Westbrook M, Ramo D, Sarkar U . Representations of Codeine Misuse on Instagram: Content Analysis. JMIR Public Health Surveill. 2018; 4(1):e22. PMC: 5883072. DOI: 10.2196/publichealth.8144. View

10.

Avena N, Simkus J, Lewandowski A, Gold M, Potenza M . Substance Use Disorders and Behavioral Addictions During the COVID-19 Pandemic and COVID-19-Related Restrictions. Front Psychiatry. 2021; 12:653674. PMC: 8085389. DOI: 10.3389/fpsyt.2021.653674. View

11.

Motyka M, Al-Imam A . Representations of Psychoactive Drugs' Use in Mass Culture and Their Impact on Audiences. Int J Environ Res Public Health. 2021; 18(11). PMC: 8199904. DOI: 10.3390/ijerph18116000. View

12.

Rutherford B, Lim C, Johnson B, Cheng B, Chung J, Huang S . #TurntTrending: a systematic review of substance use portrayals on social media platforms. Addiction. 2022; 118(2):206-217. PMC: 10087142. DOI: 10.1111/add.16020. View

13.

Rehm J . Patterns of drinking and disease-free living: Only a problem for alcohol abusers?. Lancet Reg Health Eur. 2022; 19:100432. PMC: 9253699. DOI: 10.1016/j.lanepe.2022.100432. View

14.

Lapeyre-Mestre M, Boucher A, Daveluy A, Gibaja V, Jouanjus E, Mallaret M . Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Therapie. 2020; 75(4):343-354. PMC: 7309935. DOI: 10.1016/j.therap.2020.06.006. View

15.

Raza S, Schwartz B, Lakamana S, Ge Y, Sarker A . A framework for multi-faceted content analysis of social media chatter regarding non-medical use of prescription medications. BMC Digit Health. 2023; 1. PMC: 10483682. DOI: 10.1186/s44247-023-00029-w. View

16.

Degenhardt L, Hall W . Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012; 379(9810):55-70. DOI: 10.1016/S0140-6736(11)61138-0. View

17.

Zhao Y . COVID-19 as a catalyst for educational change. Prospects (Paris). 2020; 49(1-2):29-33. PMC: 7287028. DOI: 10.1007/s11125-020-09477-y. View

18.

Depue J, Southwell B, Betzner A, Walsh B . Encoded exposure to tobacco use in social media predicts subsequent smoking behavior. Am J Health Promot. 2014; 29(4):259-61. DOI: 10.4278/ajhp.130214-ARB-69. View

19.

Giommoni L . Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets. Int J Drug Policy. 2020; 83:102834. PMC: 7332913. DOI: 10.1016/j.drugpo.2020.102834. View

20.

Al-Rawi A . The convergence of social media and other communication technologies in the promotion of illicit and controlled drugs. J Public Health (Oxf). 2020; 44(1):e153-e160. DOI: 10.1093/pubmed/fdaa210. View